MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s0195-668x(02)00740-6

Медицинская библиотека · European heart journal · 2003

A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies.

Cittadini Antonio, Ines Comi Lucia, Longobardi Salvatore, Rocco Petretta Vito, Casaburi Cosma, Passamano Luigia, Merola Bartolomeo, Durante-Mangoni Emanuele, Saccà Luigi, Politano Luisa

Клиническое исследованиеСтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIM: Since growth hormone (GH) has proven beneficial in experimental heart failure, and the natural history of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) is frequently complicated by the development of dilated cardiomyopathy, we administered GH to six patients with DMD and 10 with BMD, with the evidence of cardiac involvement.

METHODS AND

RESULTS

Patients were randomized to receive for 3 months either placebo or recombinant human GH, in a double-blind fashion. In GH-treated patients, left ventricular (LV) mass increased by 16% in BMD and by 29% in DMD (both p<0.01), with a significant increase of relative wall thickness (+19%). Systemic blood pressure remained unchanged, while LV end-systolic stress fell significantly by 13% in BMD and by 33% in DMD, with a slight increase of systolic function indexes. No changes were observed related to cardiac arrhythmias and skeletal muscle function in the patient groups during the treatment period, nor any side effects were observed. Brain natriuretic peptide, interleukin-6, and tumor necrosis factor-alpha circulating levels were elevated at baseline. While brain natriuretic peptide decreased by 40%, cytokine levels did not exhibit significant variations during the treatment period.

CONCLUSIONS

The 3-month GH therapy in patients with DMD and BMD induces a hypertrophic response associated with a significant reduction of brain natriuretic peptide plasma levels and a slight improvement of systolic function, no changes in skeletal muscle function, and no side effects.

Для цитирования: Cittadini Antonio, Ines Comi Lucia, Longobardi Salvatore, Rocco Petretta Vito, Casaburi Cosma, Passamano Luigia, Merola Bartolomeo, Durante-Mangoni Emanuele, Saccà Luigi, Politano Luisa. A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies.. European heart journal. 2003. DOI: 10.1016/s0195-668x(02)00740-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.